510(k) Report

510(k) · Cleared

Cleared

Liquichek Urine Toxicology Control (Confirmatory Series)

K033404510(k) TraditionalCleared Dec 12, 200349-day reviewClass I21 CFR 862.3280

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · DIF Drug Mixture Control Materials

Cleared on Dec 12, 2003 as substantially equivalent to K021384 (Bio-Rad, 2002) after a 49-day review. Its family tree reaches back 3 generations to 1990. 1 later device descends from it.

Decided
Dec 12, 2003
Review
49 days
Class
Class I
Product code
DIF
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K903430 (1990). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK903430 Liquichek CK/LD Isoenzyme Control; Levels 1 and 2Bio-Rad · 1990
  2. 2 generations backK981590 Liquichek Urine Toxicology Control Level C1, Liquichek Urine…Bio-Rad · 1998
  3. 1 generation backK021384 Liquichek Urine Toxicology Control Levels C1-C4, Models…Bio-Rad · 2002
  4. This deviceK033404 Liquichek Urine Toxicology Control (Confirmatory Series)Bio-Rad · 2003
  5. Descendant · cites it directly · 0 of its ownK050682 Liquichek Urine Toxicology Control (Level C1)Bio-Rad Laboratories, Inc. · 2005

Most influential descendants

Showing 1 of 1 · See all
  • K050682Liquichek Urine Toxicology Control (Level C1)Bio-Rad Laboratories, Inc. · 2005 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K903430Liquichek CK/LD Isoenzyme Control; Levels 1 and 2Bio-Rad1990—
−2K981590Liquichek Urine Toxicology Control Level C1, Liquichek Urine Toxicology…Bio-Rad1998—
−1K021384Liquichek Urine Toxicology Control Levels C1-C4, Models 441,442,443,444Bio-Rad2002—
0 (this device)K033404Liquichek Urine Toxicology Control (Confirmatory Series)Bio-Rad2003—
+1K050682Liquichek Urine Toxicology Control (Level C1)Bio-Rad Laboratories, Inc.2005—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
FIG. 1 — Lineage of K033404, 1990–2005Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DIF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021384Liquichek Urine Toxicology Control Levels C1-C4, Models 441,442,443,444
Summary page 1
…is Claimed Liquichek Urine Toxicology Control Levels C1, C2, C3 and C4 Bio-Rad Laboratories Irvine, California Docket Number: K021384 4.0 Description of Device Liquichek Urine Toxicology Controls are prepared from human urine with added drugs of…
Bio-Rad2002—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K050682Liquichek Urine Toxicology Control (Level C1)Bio-Rad Laboratories, Inc.20050

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 1 company; a new generation was cleared every 4.0 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K050682 (Bio-Rad Laboratories, Inc., 2005) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DIF devices

DIF Drug Mixture Control Materials: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DIF

1in 2016

2007: 12008: 22010: 12011: 12012: 32013: 22016: 1
2007high 3 (2012) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DIF

35in 2012

2012: 35 days median
2007high 35 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DIF

1in 2021

2011: 12013: 12017: 52021: 1
2007high 5 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DIF

1in 2016

2011: 12012: 32016: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code DIF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
20090—00
20101—00
20111—11
201233503
20132—10
20140—00
20150—00
20161—01
20170—50
20180—00
20190—00
20200—00
20210—10
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Liquichek Urine Toxicology Control is intended for use as a quality control urine to monitor the performance of laboratory urine toxicology confirmatory procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K033404: Liquichek Urine Toxicology Control (Confirmatory Series).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K033404

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026